HTHT
IRWD icon

Hemenway Trust Hemenway Trust’s Ironwood Pharmaceuticals IRWD Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-16,274
Closed -$210K – 135
2018
Q1 		$210K Hold
16,274
– – 0.04% 136
2017
Q4 		$204K Buy
+16,274
New +$213K 0.04% 141

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hemenway Trust Hemenway Trust's IRWD Position: Q2 2018 in Review

Hemenway Trust Hemenway Trust sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2018, closing a stake of 16,274 shares — an estimated $210K sold.

Hemenway Trust Hemenway Trust first reported a position in IRWD in Q4 2017 and held it in 2 quarters. The position peaked at $210K in Q1 2018. 148 funds tracked by Wall St. Rank hold IRWD as of Q2 2018.

  • Hemenway Trust Hemenway Trust reported no remaining Ironwood Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Hemenway Trust Hemenway Trust sold 16,274 Ironwood Pharmaceuticals shares in Q2 2018, an estimated $210K.
  • Hemenway Trust Hemenway Trust first reported a position in Ironwood Pharmaceuticals in Q4 2017 and held it in 2 quarters.
  • Hemenway Trust Hemenway Trust's Ironwood Pharmaceuticals position peaked at $210K in Q1 2018.
  • 148 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2018.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q2 2018, filed 30 Jul 2018.